跳至主要内容
临床试验/EUCTR2011-001820-39-DK
EUCTR2011-001820-39-DK进行中(未招募)不适用

evothyroxine for euthyroid women with recurrent miscarriage and thyroid autoimmunity : a randomized controlled trial - T4Life

Academic medical centre0 个研究点目标入组 240 人开始时间: 2013年8月15日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
240

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • 1.Women with unexplained RM and thyroid autoimmunity. Recurrent miscarriage is defined as two or more miscarriages. TPOAb positivity is defined as a TPO titre higher then 100 kU/ltr or two times higher then 60 kU/ltr.
  • 2.Age 18 - 42 years at randomisation
  • 3.Willing and able to give informed consent (IC).
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 240
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1.Antiphospholipid syndrome (lupus anticoagulant and/ or anticardiolipin antibodies [IgG or IgM])
  • 2. Other auto-immune conditions
  • 3.Previous enrolment in the trial
  • 4. Abnormal TSH levels
  • 5. Contraindications to levothyroxine use:
  • Adrenal or pituitary disorders, untreated
  • Thyreotoxicosis, untreated
  • Acute cardiac arrest
  • Acute pancreatitis
  • Acute myocarditis

研究者

发起方
Academic medical centre

相似试验

evothyroxine for recurrent miscarriage | 临床试验